PSI Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-126
| Closed | -$4.24K | – | 828 |
|
2024
Q4 | $4.24K | Buy |
126
+1
| +0.8% | +$34 | ﹤0.01% | 644 |
|
2024
Q3 | $5.07K | Buy |
125
+2
| +2% | +$81 | ﹤0.01% | 656 |
|
2024
Q2 | $4.73K | Buy |
123
+1
| +0.8% | +$38 | ﹤0.01% | 648 |
|
2024
Q1 | $5.22K | Buy |
122
+1
| +0.8% | +$43 | ﹤0.01% | 589 |
|
2023
Q4 | $4.47K | Sell |
121
-775
| -86% | -$28.6K | ﹤0.01% | 645 |
|
2023
Q3 | $32.5K | Buy |
896
+2
| +0.2% | +$72 | 0.01% | 310 |
|
2023
Q2 | $31.9K | Buy |
894
+1
| +0.1% | +$36 | 0.01% | 313 |
|
2023
Q1 | $31.8K | Buy |
893
+1
| +0.1% | +$36 | 0.02% | 276 |
|
2022
Q4 | $31.4K | Sell |
892
-719
| -45% | -$25.3K | 0.02% | 269 |
|
2022
Q3 | $47K | Sell |
1,611
-608
| -27% | -$17.7K | 0.02% | 233 |
|
2022
Q2 | $121K | Sell |
2,219
-43
| -2% | -$2.35K | 0.06% | 158 |
|
2022
Q1 | $123K | Sell |
2,262
-78
| -3% | -$4.24K | 0.05% | 178 |
|
2021
Q4 | $129K | Sell |
2,340
-98
| -4% | -$5.4K | 0.05% | 178 |
|
2021
Q3 | $116K | Buy |
+2,438
| New | +$116K | 0.05% | 185 |
|
2020
Q2 | – | Sell |
-5,790
| Closed | -$274K | – | 117 |
|
2020
Q1 | $274K | Sell |
5,790
-886
| -13% | -$41.9K | 0.25% | 80 |
|
2019
Q4 | $392K | Buy |
+6,676
| New | +$392K | 0.25% | 83 |
|